pyctx.com | ACN 098 391 961 1 3 September 2026 ADOA PROGRAM - DATA PRESENTATION AT NOSA 2026 • PYC is a precision medicine company dedicated to changing the lives of patients with genetic diseases who have no treatment options available • The Company is progressing a drug...
ADOA Program - Data Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
In the deck
Earlier from PYC Therapeutics
- Ceasing to be a substantial holder
- PKD - Presentation of Clinical Safety Data
- 2026 Corporate Governance Statement
- Appendix 4G
- 2026 Annual Report to Shareholders
Later from PYC Therapeutics
- Investor Webinar Presentation Q3 2026
- S&P DJI Announces September 2026 Quarterly Rebalance
- PKD - First Patient Dosed in OLE Study
- RP11 program - presentation at euretina 2026
- PKD Program - Presentation of Data at ASN Conference
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics